Better Therapeutics, Inc. reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported net loss was USD 11.41 million compared to USD 12.46 million a year ago. Basic loss per share from continuing operations was USD 0.48.
For the nine months, net loss was USD 31 million compared to USD 26.44 million a year ago. Basic loss per share from continuing operations was USD 1.32.